State Government Agencies

In this webinar, CDC and HRSA speakers review the calendar year 2027–2031 Integrated HIV Prevention & Care Plan Guidance—highlighting key updates, submission requirements, and real-world recipient examples. The training equips CDC- and HRSA-funded jurisdictions with technical support, planning tools, and strategies to develop coordinated HIV prevention and care efforts by the June 30, 2026 deadline.

This webpage presents data on newly reported chronic hepatitis C cases in Alaska from 2016 to 2023. It underscores the importance of continued hepatitis C surveillance to guide targeted testing and treatment efforts toward disease elimination.

This report outlines progress toward eliminating mother-to-child transmission of hepatitis B virus (HBV) in the Americas from 2012 to 2022. It highlights improvements in vaccination coverage, including birth doses, but also notes coverage declines in some countries, which could hinder elimination goals. The report emphasizes the need for maintaining high vaccination rates, expanding hepatitis B testing for pregnant women, and ensuring timely treatment for newborns.

This report proposes policies for expanding access to hepatitis C (HCV) testing and treatment in United States jails and prisons. The report's policy recommendations draw principally from settlement agreements, judicial opinions, and other filings in those cases, supplemented by current medical guidance and input from public health experts, medical professionals, and advocates.

This report lays out the required sections that must be included in a state’s Section 1115 Demonstration application and identifies where and how a state can be explicit about its intent to address the health care needs of individuals with hepatitis C as part of its Justice-Involved Reentry Initiative.

RAISE & NASTAD’s webinar, “Methods for Assessing the Landscape of STI & HIV Services in Local Health Jurisdictions ” was held on Thursday, October 24th. The webinar discusses methods for conducting landscape analyses of STI & HIV services in local health jurisdictions. University of Washington researchers presented the rational for doing a landscape analysis, methods for data collection and analysis, and layering on patient-level data to complement provider-level findings.

This infographic from HepVu illustrates hepatitis C treatment restrictions in 2024 and how many states have other requirements that reduce access to hepatitis C care.

This webinar reviews NACCHO's congenital syphilis compendium and highlights programs across the country implementing policies and practices that interrupt congenital syphilis and perinatal HIV transmission.

This webinar highlights best practices and challenges for HCV elimination with a specific focus on high-burden populations.

The webinar walks through the HepVu 2022 Viral Hepatitis Surveillance Status Report.